Target intelligence / Profile preview

Penicillin-binding protein 2; Penicillin-binding protein 3; Penicillin-binding protein 4 (PBP2; PBP3; PBP4)

Target
PBP2; PBP3; PBP4
Molecular classification
Enzyme, Transpeptidase, Carboxypeptidase, Endopeptidase, Cell wall biosynthesis protein, Peptidoglycan synthetase
01

Overview

Penicillin-binding proteins 2, 3, and 4 are members of a family of enzymes responsible for the final steps of bacterial cell wall (peptidoglycan) biosynthesis, specifically the transpeptidation and, in the case of PBP4 also, carboxypeptidation/endopeptidati on reactions necessary for cross-linking glycan chains and maintaining bacterial cell wall integrity. They serve as the molecular targets for β-lactam antibiotics, which inhibit their function by mimicking the natural D-Ala-D-Ala substrate and irreversibly acylating the active site serine residue, thereby preventing proper cell wall formation and resulting in bacterial death. PBP2 and PBP3 belong to class B PBPs and are essential for cell elongation and division, respectively; PBP4 is a class C low-molecular-mass PBP implicated in cell wall maturation and antibiotic resistance.

Other names
PBPsClass B penicillin-binding proteinstranspeptidases (for PBP2 and PBP3)bifunctional PBPsFtsI (PBP3)RodA-PBP2 complex
02

Mechanism of action

β-lactam antibiotics covalently bind to the active site serine residue of PBPs, forming an acyl-enzyme complex. This irreversible binding blocks the transpeptidase (and in some cases carboxypeptidase/endopeptidase) activity, thereby inhibiting peptidoglycan cross-linking and disrupting bacterial cell wall synthesis, which ultimately leads to bacterial cell lysis and death.

03

Biological functions

Peptidoglycan synthesisCell divisionCell wall maintenance and elongationShape determination
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Antibiotic resistance due to PBP mutations (can lead to reduced drug efficacy)Therapeutic challenge: differences in affinity and access among bacterial species and strains can affect response to β-lactam drugs
06

Interacting drugs

β-lactam antibiotics

7 more in the full profile.

Beyond the preview

Go deeper on Penicillin-binding protein 2; Penicillin-binding protein 3; Penicillin-binding protein 4 (PBP2; PBP3; PBP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 2; Penicillin-binding protein 3; Penicillin-binding protein 4 (PBP2; PBP3; PBP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call